Livongo Health (LVGO +8.3%) is up out of the gate in reaction to the award of a contract for its Diabetes solution from the Federal Employees Health Benefits Program covering ~5.3M employees, retirees and family members with type 1 or 2 diabetes.
The two-year agreement, commencing on January 1, 2020, will add ~25K Diabetes Members next year and ~45K in 2021. Additional revenue should be $20M - 25M in 2020 and $30M - 35M the year after.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.